Efficacy and safety of a novel low-dose triple single-pill combination of telmisartan, amlodipine and indapamide, compared with dual combinations for treatment of hypertension: a randomised, double-blind, active-controlled, international clinical trial

作者：Anthony Rodgers, Abdul Salam, Aletta E. Schutte, William C. Cushman, H Asita de Silva, Gian Luca Di Tanna, Diederick E. Grobbee, Krzysztof Narkiewicz, Dike Ojji, Neil R Poulter, Markus P. Schlaich, Suzanne Oparil, Wilko Spiering, Bryan Williams, Jackson T. Wright, Poopalan Lakshman, W. Uluwattage, Peter Hay, Tiago Pereira, Najith Amarasena, Gotabhaya Ranasinghe, Christopher Gianacas, Mathangi Shanthakumar, Xiaoqiu Liu, Nelson Wang, Sonali R. Gnanenthiran, Paul K. Whelton · 发表于：The Lancet · 年份：2024 · DOI：10.1016/s0140-6736(24)01744-6 · 被引用次数：38 · 研究领域：Blood Pressure and Hypertension Studies、Renin-Angiotensin System Studies、Pharmaceutical Economics and Policy